Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bain Capital’s Brookside Capital Dumped Apple Inc. (AAPL) and Bought These Stocks

Page 1 of 2

At the end of September, Apple Inc. (NASDAQ:AAPL) was the largest holding by market value in Brookside Capital’s portfolio. However, by the end of the fourth quarter of 2012 the hedge fund (which is part of the larger Bain Capital alternative investments group) had sold all of its Apple Inc. (NASDAQ:AAPL) shares, according to our database of 13F filings. We track 13Fs from hedge funds and other notable investors as part of our work researching investment strategies; we have found that the most popular small cap stocks among hedge funds earn an average excess return of 18 percentage points per year (learn more about our small cap strategy) and believe that more techniques are possible as well.

Apple Inc. (NASDAQ:AAPL)

However, we also keep track of major changes in hedge fund sentiment, and one of these took place between October and December of last year with regards to Apple Inc. (NASDAQ:AAPL). With a number of hedge funds selling shares, it lost its place as the most popular stock among hedge funds to American International Group Inc (NYSE:AIG). Find more stocks hedge funds loved. We have been investigating some of the funds which sold out of Apple, including Brookside, to see what they were buying instead. Read on for our look at two positions the fund increased last quarter or see the full list of stocks Bain’s equity hedge fund reported owning.

The new top pick in the portfolio, fueled by an increase of almost 300% in the size of Brookside’s position, was Express Scripts Holding Company (NASDAQ:ESRX). The $48 billion market cap pharmacy benefit management services company was embroiled in a dispute with pharmacy Walgreen Company (NYSE:WAG) for part of last year, damaging its business. Revenue and earnings have returned nicely, however, and Express Scripts actually made our list of the most popular healthcare stocks among hedge funds as of the end of December (check out more of hedge funds’ healthcare picks). While the trailing earnings multiple is 38, that includes a substantial period when earnings were depressed because of the Walgreen’s issue. In the fourth quarter of 2012 the company reported $1.05 in earnings per share; if we annualize that figure we get a P/E multiple of only 14, with some potential for further growth as the U.S. population ages and consumes more prescription drugs.

Page 1 of 2
Loading...